Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results Mar 28, 2022 4:47pm EDT
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers Mar 23, 2022 8:25am EDT
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System Mar 17, 2022 8:25am EDT
PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board Mar 10, 2022 8:25am EST
Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022 Mar 07, 2022 8:30am EST
PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth Mar 03, 2022 8:25am EST
